Literature DB >> 1444476

Crystal structure of peroxynitrite-modified bovine Cu,Zn superoxide dismutase.

C D Smith1, M Carson, M van der Woerd, J Chen, H Ischiropoulos, J S Beckman.   

Abstract

The crystal structure of bovine Cu,Zn superoxide dismutase modified with peroxynitrite (ONOO-) was determined by X-ray diffraction, utilizing the existing three-dimensional model of the native structure deposited in the Brookhaven Protein Data Bank (J. A. Tainer et al., J. Mol. Biol. 160, 181-217, 1982). The native structure and the modified derivative were refined to R factors of 19.0 and 18.7% respectively using diffraction data from 6.0 to 2.5 A. The major result after reaction with peroxynitrite was the appearance of electron density 1.45 A from a single epsilon carbon of Tyr-108, the only tyrosine residue in the sequence. Tyr-108 is a solvent-exposed residue 18 A from the copper atom in the active site. The electron density was consistent with nitration of Tyr-108 at one of the epsilon carbons to form 3-nitrotyrosine. We propose that the nitration occurs in solution by transfer of a nitronium-like species from the active site on one superoxide dismutase dimer to the Tyr-108 of a second dimer.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1444476     DOI: 10.1016/0003-9861(92)90286-6

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  17 in total

1.  Confident identification of 3-nitrotyrosine modifications in mass spectral data across multiple mass spectrometry platforms.

Authors:  Bensheng Li; Jason M Held; Birgit Schilling; Steven R Danielson; Bradford W Gibson
Journal:  J Proteomics       Date:  2011-04-15       Impact factor: 4.044

Review 2.  A role for copper in the toxicity of zinc-deficient superoxide dismutase to motor neurons in amyotrophic lateral sclerosis.

Authors:  Kari A Trumbull; Joseph S Beckman
Journal:  Antioxid Redox Signal       Date:  2009-07       Impact factor: 8.401

3.  Peroxynitrite-induced nitration of tyrosine-34 does not inhibit Escherichia coli iron superoxide dismutase.

Authors:  L Soulère; C Claparols; J Périé; P Hoffmann
Journal:  Biochem J       Date:  2001-12-15       Impact factor: 3.857

Review 4.  Oxygen radicals, nitric oxide, and peroxynitrite: Redox pathways in molecular medicine.

Authors:  Rafael Radi
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-25       Impact factor: 11.205

5.  Pentachlorophenol molecule design with lower bioconcentration through 3D-QSAR associated with molecule docking.

Authors:  Xiaolei Wang; Zhenhua Chu; Jiawen Yang; Yu Li
Journal:  Environ Sci Pollut Res Int       Date:  2017-09-18       Impact factor: 4.223

6.  Characterization of a cellular denitrase activity that reverses nitration of cyclooxygenase.

Authors:  Ruba S Deeb; Tal Nuriel; Cynthia Cheung; Barbara Summers; Brian D Lamon; Steven S Gross; David P Hajjar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-06-21       Impact factor: 4.733

7.  Supraspinal inactivation of mitochondrial superoxide dismutase is a source of peroxynitrite in the development of morphine antinociceptive tolerance.

Authors:  T Doyle; L Bryant; I Batinic-Haberle; J Little; S Cuzzocrea; E Masini; I Spasojevic; D Salvemini
Journal:  Neuroscience       Date:  2009-07-14       Impact factor: 3.590

8.  Neuroprotective efficacy and therapeutic time window of peroxynitrite decomposition catalysts in focal cerebral ischemia in rats.

Authors:  Meenakshisundaram Thiyagarajan; Chaman Lal Kaul; Shyam Sundar Sharma
Journal:  Br J Pharmacol       Date:  2004-06-14       Impact factor: 8.739

9.  Therapeutic manipulation of peroxynitrite attenuates the development of opiate-induced antinociceptive tolerance in mice.

Authors:  Carolina Muscoli; Salvatore Cuzzocrea; Michael M Ndengele; Vincenzo Mollace; Frank Porreca; Francesca Fabrizi; Emanuela Esposito; Emanuela Masini; George M Matuschak; Daniela Salvemini
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

10.  Understanding peroxynitrite biochemistry and its potential for treating human diseases.

Authors:  Joseph S Beckman
Journal:  Arch Biochem Biophys       Date:  2009-04-15       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.